Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 8, 2026 21:02 UTC |
Smith Andrew AlasdairChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $0.17 | $0.00 |
DisclosureSEC source: 0000950142-26-002522 · es260826903_4-smitha.xml · derivative · entry 2 Smith Andrew Alasdair · CIK 0001309614 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Shares · 125,000 shares Expires 2031-09-04 F1 · derivative.exercise_date: The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:02 UTC |
Smith Andrew AlasdairChief Operating Officer
|
GrantCommon Shares, no par value | 735,294 | $0.17 | $125,367.63 |
DisclosureSEC source: 0000950142-26-002522 · es260826903_4-smitha.xml · nonDerivative · entry 1 Smith Andrew Alasdair · CIK 0001309614 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 735,458 Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:01 UTC |
Mehmud FaisalChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.17 | $0.00 |
DisclosureSEC source: 0000950142-26-002521 · es260826900_4-mehmud.xml · derivative · entry 2 Mehmud Faisal · CIK 0002047946 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares · 250,000 shares Expires 2031-09-04 F1 · derivative.exercise_date: The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:01 UTC |
Mehmud FaisalChief Medical Officer
|
GrantCommon Shares, no par value | 1,470,588 | $0.17 | $250,735.25 |
DisclosureSEC source: 0000950142-26-002521 · es260826900_4-mehmud.xml · nonDerivative · entry 1 Mehmud Faisal · CIK 0002047946 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,470,588 Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:01 UTC |
Brennan Edward J.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.17 | $0.00 |
DisclosureSEC source: 0000950142-26-002520 · es260826894_4-brennan.xml · derivative · entry 2 Brennan Edward J. · CIK 0002048104 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2031-09-04 F1 · derivative.exercise_date: The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:01 UTC |
Brennan Edward J.Chief Scientific Officer
|
GrantCommon Shares, no par value | 588,235 | $0.17 | $100,294.07 |
DisclosureSEC source: 0000950142-26-002520 · es260826894_4-brennan.xml · nonDerivative · entry 1 Brennan Edward J. · CIK 0002048104 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 674,735 Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:00 UTC |
Bonner Carolyn F.President and CFO
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.17 | $0.00 |
DisclosureSEC source: 0000950142-26-002519 · es260826893_4-bonner.xml · derivative · entry 2 Bonner Carolyn F. · CIK 0002047487 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares · 250,000 shares Expires 2031-09-04 F1 · derivative.exercise_date: The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:00 UTC |
Bonner Carolyn F.President and CFO
|
GrantCommon Shares, no par value | 1,470,588 | $0.17 | $250,735.25 |
DisclosureSEC source: 0000950142-26-002519 · es260826893_4-bonner.xml · nonDerivative · entry 1 Bonner Carolyn F. · CIK 0002047487 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,489,493 Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:00 UTC |
Bokhari RazaDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.17 | $0.00 |
DisclosureSEC source: 0000950142-26-002518 · es260826892_4-bokhari.xml · derivative · entry 2 Bokhari Raza · CIK 0001660525 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Shares · 500,000 shares Expires 2031-09-04 F1 · derivative.exercise_date: The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| September 04, 2026 Filed Sep 8, 2026 21:00 UTC |
Bokhari RazaDirector · Chief Executive Officer
|
GrantCommon Shares, no par value | 2,941,176 | $0.17 | $501,470.51 |
DisclosureSEC source: 0000950142-26-002518 · es260826892_4-bokhari.xml · nonDerivative · entry 1 Bokhari Raza · CIK 0001660525 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,941,176 Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:16 UTC |
Raju AjayDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001641 · es260786893_4-raju.xml · derivative · entry 1 Raju Ajay · CIK 0002049841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:13 UTC |
May Sara R.Director
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001639 · es260786891_4-may.xml · derivative · entry 1 May Sara R. · CIK 0002048946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:07 UTC |
Ciaruffoli Robert J.Director
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001635 · es260786887_4-ciaruffoli.xml · derivative · entry 1 Ciaruffoli Robert J. · CIK 0002048095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:05 UTC |
Brennan Edward J.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001634 · es260786886_4-brennan.xml · derivative · entry 1 Brennan Edward J. · CIK 0002048104 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:15 UTC |
Mehmud FaisalChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001640 · es260786892_4-mehmud.xml · derivative · entry 1 Mehmud Faisal · CIK 0002047946 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares · 250,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:03 UTC |
Bonner Carolyn F.President and CFO
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001633 · es260786885_4-bonner.xml · derivative · entry 1 Bonner Carolyn F. · CIK 0002047487 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares · 250,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:19 UTC |
Smith Andrew AlasdairChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001643 · es260786895_4-smitha.xml · derivative · entry 1 Smith Andrew Alasdair · CIK 0001309614 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Shares · 200,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:17 UTC |
Rodgers Cathy McMorrisDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001642 · es260786894_4-rodgers.xml · derivative · entry 1 Rodgers Cathy McMorris · CIK 0002078262 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:12 UTC |
MAHAFFY PATRICK JDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001638 · es260786890_4-mahaffy.xml · derivative · entry 1 MAHAFFY PATRICK J · CIK 0001266569 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:11 UTC |
Kaiser LarryDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001637 · es260786889_4-kaiser.xml · derivative · entry 1 Kaiser Larry · CIK 0002048184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:09 UTC |
FISHMAN BARRYDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001636 · es260786888_4-fishman.xml · derivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:01 UTC |
Bokhari RazaDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001632 · es260786884_4-bokharii.xml · derivative · entry 1 Bokhari Raza · CIK 0001660525 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Shares · 500,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:00 UTC |
Ashton WilliamDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001631 · es260786882_4-ashton.xml · derivative · entry 1 Ashton William · CIK 0001474553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:18 UTC |
Raju AjayDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001031 · es260758778_4-raju.xml · derivative · entry 1 Raju Ajay · CIK 0002049841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:15 UTC |
May Sara R.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001029 · es260758774_4-may.xml · derivative · entry 1 May Sara R. · CIK 0002048946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:09 UTC |
Ciaruffoli Robert J.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001025 · es260758764_4-ciaruffoli.xml · derivative · entry 1 Ciaruffoli Robert J. · CIK 0002048095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:08 UTC |
Brennan Edward J.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001024 · es260758763_4-brennan.xml · derivative · entry 1 Brennan Edward J. · CIK 0002048104 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:17 UTC |
Mehmud FaisalChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001030 · es260758775_4-mehmud.xml · derivative · entry 1 Mehmud Faisal · CIK 0002047946 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Shares · 125,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:07 UTC |
Bonner Carolyn F.President and CFO
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001023 · es260758761_4-bonner.xml · derivative · entry 1 Bonner Carolyn F. · CIK 0002047487 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:22 UTC |
Smith Andrew AlasdairChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001033 · es260758781_4-smitha.xml · derivative · entry 1 Smith Andrew Alasdair · CIK 0001309614 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:20 UTC |
Rodgers Cathy McMorrisDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001032 · es260758780_4-rodgers.xml · derivative · entry 1 Rodgers Cathy McMorris · CIK 0002078262 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:14 UTC |
MAHAFFY PATRICK JDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001028 · es260758773_4-mahaffy.xml · derivative · entry 1 MAHAFFY PATRICK J · CIK 0001266569 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:12 UTC |
Kaiser LarryDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001027 · es260758772_4-kaiser.xml · derivative · entry 1 Kaiser Larry · CIK 0002048184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:11 UTC |
FISHMAN BARRYDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001026 · es260758765_4-fishman.xml · derivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:05 UTC |
Bokhari RazaDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 325,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001022 · es260758759_4-bokhari.xml · derivative · entry 1 Bokhari Raza · CIK 0001660525 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,000 Underlying: Common Shares · 325,000 shares Expires 2031-03-27 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:03 UTC |
Ashton WilliamDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001021 · es260758758_4-ashton.xml · derivative · entry 1 Ashton William · CIK 0001474553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:09 UTC |
Raju AjayDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003239 · es250717285_4-raju.xml · derivative · entry 1 Raju Ajay · CIK 0002049841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:08 UTC |
Ciaruffoli Robert J.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003233 · es250717261_4-ciaruffoli.xml · derivative · entry 1 Ciaruffoli Robert J. · CIK 0002048095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:09 UTC |
May Sara R.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003237 · es250717283_4-may.xml · derivative · entry 1 May Sara R. · CIK 0002048946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:07 UTC |
Brennan Edward J.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003232 · es250717260_4-brennan.xml · derivative · entry 1 Brennan Edward J. · CIK 0002048104 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:09 UTC |
Mehmud FaisalChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003238 · es250717284_4-mehmud.xml · derivative · entry 1 Mehmud Faisal · CIK 0002047946 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Shares · 75,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:07 UTC |
Bonner Carolyn F.President and CFO
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003231 · es250658436_4-bonner.xml · derivative · entry 1 Bonner Carolyn F. · CIK 0002047487 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Shares · 75,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:10 UTC |
Smith Andrew AlasdairChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003241 · es250717288_4-smitha.xml · derivative · entry 1 Smith Andrew Alasdair · CIK 0001309614 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:09 UTC |
Rodgers Cathy McMorrisDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003240 · es250717286_4-rodgers.xml · derivative · entry 1 Rodgers Cathy McMorris · CIK 0002078262 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:08 UTC |
MAHAFFY PATRICK JDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003236 · es250717282_4-mahaffy.xml · derivative · entry 1 MAHAFFY PATRICK J · CIK 0001266569 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:08 UTC |
Kaiser LarryDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003235 · es250717265_4-kaiser.xml · derivative · entry 1 Kaiser Larry · CIK 0002048184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:06 UTC |
Bokhari RazaDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003230 · es250717258_4-bokhari.xml · derivative · entry 1 Bokhari Raza · CIK 0001660525 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Shares · 125,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:08 UTC |
FISHMAN BARRYDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003234 · es250717263_4-fishman.xml · derivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:06 UTC |
Ashton WilliamDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003229 · es250717256_4-ashton.xml · derivative · entry 1 Ashton William · CIK 0001474553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| August 13, 2025 Filed Aug 14, 2025 16:01 UTC |
Quinlan James P.Chief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0000950142-25-002189 · es250667851_4-quinlan.xml · derivative · entry 4 Quinlan James P. · CIK 0002047493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 20,000 shares Expires 2029-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024. F3 · derivative.exercise_date: The option was vested and was exercisable as of the Transaction Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.